1-3 of 3
Grace Watson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Day 30 SUV max predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy

Ajlan Al Zaki, Lei Feng, Grace Watson, Sairah A. Ahmed, Haleigh Mistry, Loretta J. Nastoupil, Misha Hawkins, Ranjit Nair, Swaminathan P. Iyer, Hun J. Lee, Raphael E. Steiner, Christopher R. Flowers, Elizabeth J. Shpall, Partow Kebriaei, Sattva S. Neelapu, Jason R. Westin, Paolo Strati
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2867–2871.
https://doi.org/10.1182/bloodadvances.2021006715
Published: 2022
Includes: Supplemental data
Journal Articles

A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy

Sushanth Gouni, Allison C. Rosenthal, Jennifer L. Crombie, Andrew Ip, Manali K. Kamdar, Brian Hess, Lei Feng, Grace Watson, Amy Ayers, Sattva S. Neelapu, Arushi Khurana, Yi Lin, Madiha Iqbal, Reid W. Merryman, Paolo Strati
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2757–2762.
https://doi.org/10.1182/bloodadvances.2021006801
Published: 2022
Journal Articles

Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma

Paolo Strati, Sairah Ahmed, Partow Kebriaei, Loretta J. Nastoupil, Catherine M. Claussen, Grace Watson, Sandra B. Horowitz, Anne Rain T. Brown, Bryan Do, Maria A. Rodriguez, Ranjit Nair, Elizabeth J. Shpall, Michael R. Green, Sattva S. Neelapu, Jason R. Westin
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3123–3127.
https://doi.org/10.1182/bloodadvances.2020002328
Published: 2020